Screening for depression in chronic obstructive pulmonary disease

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 6, Issue 6, 2009, Pages 452-458

  Julian, Laura J ^a   Gregorich, Steven E ^a   Earnest, Gillian ^a   Eisner, Mark D ^a   Chen, Hubert ^a   Blanc, Paul D ^a   Yelin, Ed H ^a   Katz, Patricia P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chronic Obstructive Pulmonary Disease; Depression; Screening; Validity

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GERIATRIC DEPRESSION SCALE; GOLD STANDARD; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCREENING;

AGE DISTRIBUTION; AGED; ANTIDEPRESSIVE AGENTS; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROBABILITY; PSYCHIATRIC STATUS RATING SCALES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; ROC CURVE; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION;

EID: 73549105911     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.3109/15412550903341463     Document Type: Article

References (47)

1. Murray CJL, Lopez AD. Summary: The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 Projected to 2020. Cambridge: Harvard University Press, 1996.
2. Wells KB, Stewart A, Hays RD, et al. The functioning and wellbeing of depressed patients: Results from the medical outcomes study. J Amer Med Asso (JAMA) 1989; 262:914-919. (Pubitemid 19208948)
3. Broadhead WE, Blazer DG, George LK, Tse CK. Depression, disability days, and days lost from work in a prospective epidemiologic survey. JAMA 1990; 264:2524-2528.
4. Spitzer RL, Kroenke K, Linzer M, et al. Health-related quality of life in primary care patients with mental disorders. Results from the PRIME-MD 1000 Study. JAMA 1995; 274:1511-1517.
5. Katon W, Berg AO, Robins AJ, Risse S. Depression-medical utilization and somatization. West J Med 1986;144:564-568.
6. Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 2007;167:60-67.
7. Gudmundsson G, Gislason T, Janson C, et al. Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J 2005;26:414-419.
8. McCathie HC, Spence SH, Tate RL. Adjustment to chronic obstructive pulmonary disease: the importance of psychological factors. Eur Respir J 2002;19:47-53.
9. Cao Z, Ong KC, Eng P, Tan WC, Ng TP. Frequent hospital readmissions for acute exacerbation of COPD and their associated factors. Respirology 2006; 11:188-195.
10. Norwood R. Prevalence and impact of depression in chronic obstructive pulmonary disease patients. Curr Opin Pulmon Med 2006; 12:113-117.
11. van Ede L, Yzermans CJ, Brouwer HJ. Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review. Thorax 1999; 54:688-692.
12. Schane RE, Woodruff PG, Dinno A, Covinsky KE, Walter LC. Prevalence and risk factors for depressive symptoms in persons with chronic obstructive pulmonary disease. J Gen Intern Med 2008; 23:1757-1762.
13. Adshead F, Cody DD, Pitt B. BASDEC: a novel screening instrument for depression in elderly medical inpatients. BMJ 1992; 305:397.
14. Abebaw M, Yohannes RCBMJC. Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. Inter J Geriat Psych 2000; 15:1090-1096.
15. Kunik ME, Azzam PN, Souchek J, et al. A practical screening tool for anxiety and depression in patients with chronic breathing disorders. Psychosomatics 2007; 48:16-21.
16. Ahmed K, Kelshiker A, Jenner C. The screening and treatment of undiagnosed depression in patients with chronic obstructive pulmonary disease (COPD) in a general practice. Prim Care Respir J 2007; 16:249-251.
17. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: A preliminary report. J Psych Res 1983; 17:37-49.
18. Sheikh JI, Yesavage JA. Recent evidence and development of a shorter version. In: Clinical Gerontology: A Guide to Assessment and Intervention. New York: Haworth Press, 1986.
19. Weintraub D, Saboe K, Stern MB. Effect of age on geriatric depression scale performance in Parkinson's disease. Movement Disorders 2007; 22:1331-1335.
20. Haworth JE, Moniz-Cook E, Clark AL,Wang M, Cleland JG. An evaluation of two self-report screening measures for mood in an out-patient chronic heart failure population. Inter J Geriat Psych 2007; 22:1147-1153.
21. Zalsman G, Weizman A, Carel CA, Aizenberg D. Geriatric Depression Scale (GDS-15): a sensitive and convenient instrument for measuring depression in young anorexic patients. J Nerv Ment Dis 2001; 189:338-339.
22. Katz PP, Yelin EH. The development of depressive symptoms among women with rheumatoid arthritis. The role of function. Arthritis Rheumat 1995; 38:49-56.
23. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini- International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psych 1998;59 Suppl 20:22-33;quiz 34-57.
24. Marc LG, Raue PJ, Bruce ML. Screening performance of the 15-item geriatric depression scale in a diverse elderly home care population. Amer J Geriat Psych 2008; 16:914-921.
25. Trupin L, Earnest G, San Pedro M, et al. The occupational burden of chronic obstructive pulmonary disease. Eur Respir J 2003; 22:462-469.
26. Kim J. Atlas of Respiratory Disease Mortality, United States: 1982-1993. Cincinnati:, Ohio: Dept of Health and Human Services, National Institute for Occupational Safety and Health, 1998.
27. Egan S, Nathan P, Lumley M. Diagnostic concordance of ICD- 10 personality and comorbid disorders: a comparison of standard clinical assessment and structured interviews in a clinical setting. Austral NZ J Psych 2003; 37:484-491.
28. Nascimento I, Nardi AE, Valenca AM, et al. Psychiatric disorders in asthmatic outpatients. Psych Res 2002; 110:73-80.
29. Ribeiro LS, Proietti FA. Interrelations between fibromyalgia, thyroid autoantibodies, and depression. J Rheumatol 2004; 31:2036-2040.
30. Houeto JL, Mesnage V, Mallet L, et al. Behavioural disorders, Parkinson's disease and subthalamic stimulation. J Neurol Neurosurg Psych 2002; 72:701-707. (Pubitemid 34557009)
31. Pauwels RA, Buist AS, Ma P, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respir Care 2001; 46:798-825.
32. American Thoracic Society. Standardization of spirometry- 1987 update. Statement of the American Thoracic Society. American Review of Respiratory Disease 1987; 136:1285-1298.
33. American Thoracic Society. Standardization of spirometry- 1987 update. Official statement of American Thoracic Society. Respir Care 1987; 32:1039-1060.
34. Perez-Padilla R, Vazquez-Garcia JC, Marquez MN, et al. The long-term stability of portable spirometers used in a multinational study of the prevalence of chronic obstructive pulmonary disease. Respir Care 2006; 51:1167-1171.
35. Walters JA, Wood-Baker R, Walls J, Johns DP. Stability of the EasyOne ultrasonic spirometer for use in general practice. Respirology 2006; 11:306-310.
36. Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a populationbased prevalence study. Lancet 2007; 370:741-750.
37. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159:179-187.
38. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163:1256-1276.
39. Fabbri LM, Hurd SS. Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update. Eur Respir J 2003; 22:1-2.
40. Youden WJ. Index for rating diagnostic tests. Cancer 1950; 3:32-35.
41. Kraemer HC. Evaluating Medical Tests: Objective and Quantitative Guidelines. Newbury Park, CA: Sage Publications, 1992.
42. Coffin M, Sukhatme S. Receiver operating characteristic studies and measurement errors. Biometrics 1997; 53:823-837.
43. Chopra MP, Zubritsky C, Knott K, et al. Importance of subsyndromal symptoms of depression in elderly patients. Amer J Geriat Psych 2005; 13:597-606.
44. Judd LL, Paulus MP, Wells KB, Rapaport MH. Socioeconomic burden of subsyndromal depressive symptoms and major depression in a sample of the general population. Amer J Psych 1996; 153:1411-1417.
45. Johnson J, Weissman MM, Klerman GL. Service utilization and social morbidity associated with depressive symptoms in the community. JAMA 1992; 267:1478-1483.
46. Wells KB, Stewart A, Hays RD, et al. The functioning and wellbeing of depressed patients. Results from the Medical Outcomes Study. JAMA 1989; 262:914-919. (Pubitemid 19208948)
47. Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA 2005; 294:1255-1259.